US-based Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry, is opening a lead optimisation laboratory in Genome Valley, Hyderabad—the “Life Science Capital of India,” which is home to more than 200 life science and pharmaceutical companies including Novartis and Lonza.

Enveda’s 24,000-square-foot space there will bolster the company’s growing workforce in India and enable it to more efficiently optimize lead compounds to identify clinical drug candidates.

The Genome Valley laboratory will house imaging instruments, automated liquid handlers, and analysis software, among other state-of-the-art synthetic chemistry technologies used in the lead optimization cycle. The company expects to move into the new laboratory by the end of 2022. Enveda can expand its space in Hyderabad to accommodate nearly triple its current workforce.

The company is also building out an advanced drug discovery and development center in the heart of Boulder, Colorado in the US. The 60,000-square-foot facility will significantly expand Enveda’s capacity to build a high-resolution chemical map of the natural world and identify new high-potential drug leads from it.